![[刘小婷]](https://staticres.ablesci.com/avatar/u/b901337a524b2f8aa312b155bd115e5c.png?v=5b0f)
Lv62
2690 积分 2022-09-21 加入
A Novel HER3-Targeting Antibody–Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization
13天前
已完结
Exploring the next generation of antibody–drug conjugates
13天前
已完结
Gene therapy for chronic pain: emerging opportunities in target-rich peripheral nociceptors
25天前
已完结
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy
25天前
已完结
HCN3 ion channels: roles in sensory neuronal excitability and pain
25天前
已完结
Protein kinase A regulates inflammatory pain sensitization by modulating HCN2 channel activity in nociceptive sensory neurons
25天前
已关闭
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
26天前
已完结
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
1个月前
已完结
Abstract 341: VBC108: a first-in-class CDH17/CLDN18.2 targeted bispecific antibody drug conjugate (ADC) to overcome tumor heterogeneity of gastrointestinal cancers (GC, PADC, CRC, etc.)
1个月前
已关闭
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
1个月前
已完结
皖公网安备34019202002308
